BEAM

Beam Therapeutics Inc.

39.81 USD
-0.03 (-0.08%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Beam Therapeutics Inc. stock is up 53.59% since 30 days ago. The next earnings date is May 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Feb 15:50 17 May, 2024 40.00 PUT 100 100
27 Feb 15:50 17 May, 2024 40.00 PUT 300 100
27 Feb 15:50 17 May, 2024 40.00 PUT 100 100
27 Feb 15:50 17 May, 2024 40.00 PUT 99 100
27 Feb 15:50 17 May, 2024 40.00 PUT 100 100
27 Feb 15:50 17 May, 2024 40.00 PUT 100 100
27 Feb 15:53 17 May, 2024 40.00 PUT 100 100
27 Feb 15:59 17 May, 2024 40.00 PUT 84 100
27 Feb 16:25 15 Mar, 2024 50.00 CALL 150 4
27 Feb 20:13 15 Mar, 2024 45.00 CALL 66 33

About Beam Therapeutics Inc.

Beam Therapeutics Inc. develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders.